genedrive (LON:GDR) Trading 14.1% Higher – Still a Buy?

genedrive plc (LON:GDR) shot up 14.1% during trading on Tuesday . The company traded as high as GBX 1.10 and last traded at GBX 1.06. 5,884,570 shares changed hands during trading, an increase of 52% from the average session volume of 3,860,514 shares. The stock had previously closed at GBX 0.93.

genedrive Stock Up 14.1%

The business has a fifty day moving average price of GBX 0.91 and a two-hundred day moving average price of GBX 0.83. The company has a current ratio of 4.60, a quick ratio of 5.52 and a debt-to-equity ratio of 0.35. The company has a market cap of £10.86 million, a price-to-earnings ratio of -1.17 and a beta of -0.04.

About genedrive

ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.